Michael K. Elson

820 total citations
32 papers, 631 citations indexed

About

Michael K. Elson is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael K. Elson has authored 32 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Michael K. Elson's work include Radiopharmaceutical Chemistry and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Thyroid Disorders and Treatments (3 papers). Michael K. Elson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Thyroid Disorders and Treatments (3 papers). Michael K. Elson collaborates with scholars based in United States and United Kingdom. Michael K. Elson's co-authors include Rex B. Shafer, Craig J. McClain, John E. Morley, Allen S. Levine, Walter R. Hearn, Michael D. Levitt, David H. Van Thiel, Robert H. Williams, Eugene G. DeMaster and Julie Furne and has published in prestigious journals such as Nature, New England Journal of Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michael K. Elson

32 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael K. Elson United States 16 151 119 91 84 72 32 631
H Tamaki Japan 18 168 1.1× 309 2.6× 37 0.4× 46 0.5× 46 0.6× 45 800
James McQueen United Kingdom 21 224 1.5× 92 0.8× 32 0.4× 73 0.9× 118 1.6× 45 1.1k
Dianne J. Delsing Netherlands 17 197 1.3× 78 0.7× 61 0.7× 253 3.0× 102 1.4× 28 841
Gerhard H. Scholz Germany 17 403 2.7× 274 2.3× 194 2.1× 142 1.7× 158 2.2× 39 958
Mark Schiefermeier Austria 8 196 1.3× 57 0.5× 62 0.7× 37 0.4× 60 0.8× 12 538
Chihiro Sekiya Japan 15 364 2.4× 51 0.4× 78 0.9× 154 1.8× 347 4.8× 60 1.2k
Nelly Conus Australia 12 307 2.0× 56 0.5× 66 0.7× 38 0.5× 59 0.8× 15 746
S. Higuchi Japan 14 335 2.2× 56 0.5× 30 0.3× 113 1.3× 198 2.8× 22 977
Tamara Ramadan Switzerland 10 361 2.4× 83 0.7× 40 0.4× 86 1.0× 34 0.5× 11 832
Michiko Asano Japan 17 252 1.7× 200 1.7× 29 0.3× 212 2.5× 112 1.6× 51 887

Countries citing papers authored by Michael K. Elson

Since Specialization
Citations

This map shows the geographic impact of Michael K. Elson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. Elson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. Elson more than expected).

Fields of papers citing papers by Michael K. Elson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. Elson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. Elson. The network helps show where Michael K. Elson may publish in the future.

Co-authorship network of co-authors of Michael K. Elson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. Elson. A scholar is included among the top collaborators of Michael K. Elson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. Elson. Michael K. Elson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallera, Daniel A., Michael K. Elson, Martin W. Brechbiel, et al.. (2004). Radiotherapy of CD19 Expressing Daudi Tumors in Nude Mice with Yttrium-90-Labeled Anti-CD19 Antibody. Cancer Biotherapy and Radiopharmaceuticals. 19(1). 11–23. 14 indexed citations
2.
Redmon, J. Bruce, et al.. (1992). Brief Report: Hypoglycemia Due to a Monoclonal Insulin-Binding Antibody in Multiple Myeloma. New England Journal of Medicine. 326(15). 994–998. 52 indexed citations
3.
Palme, Donald F., et al.. (1991). Dosimetry and pharmacokinetics of monoclonal antibody A6H with human renal cell carcinoma xenografts: Single dose study. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 527–537. 6 indexed citations
4.
Chiou, Rei K., Robert L. Vessella, Catherine Limas, et al.. (1988). Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using a nude mouse model. Cancer. 61(9). 1766–1775. 19 indexed citations
5.
Vessella, R L, et al.. (1988). Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice.. PubMed. 1. 245–82. 10 indexed citations
6.
Shafer, Rex B., et al.. (1987). Use of In-111 anti-CEA monoclonal antibody to detect occult CEA-producing carcinoma. 1 indexed citations
7.
Mooradian, Arshag D., John E. Morley, Charles J. Billington, et al.. (1985). Hyperprolactinaemia in male diabetics. Postgraduate Medical Journal. 61(711). 11–14. 32 indexed citations
8.
Eckfeldt, J H, Joseph C. Kolars, Michael K. Elson, Rex B. Shafer, & Michael D. Levitt. (1985). Serum tests for pancreatitis in patients with abdominal pain.. PubMed. 109(4). 316–9. 26 indexed citations
9.
Knodell, Robert G., et al.. (1984). Effect of cholestasis on hepatic transport of 99mtechnetium p-isopropyl-iminodiacetic acid.. PubMed. 104(4). 517–27. 5 indexed citations
10.
Morley, John E., et al.. (1984). The role of the endogenous opiates in zinc deficiency anorexia. Physiology & Behavior. 32(3). 475–478. 31 indexed citations
11.
Elson, Michael K., John E. Morley, & Rex B. Shafer. (1983). Salivary thyroxine as an estimate of free thyroxine: concise communication.. PubMed. 24(8). 700–2. 8 indexed citations
12.
Morley, John E., Michael K. Elson, Allen S. Levine, & Rex B. Shafer. (1982). Levels of immunoreactive dynorphin in brain and pituitary of hyperthyroid and hypothyroid rats. European Journal of Pharmacology. 78(1). 125–127. 8 indexed citations
13.
Elson, Michael K., Martin M. Oken, & Rex B. Shafer. (1982). Effect of endotoxin fever on plasma clearance of thyroxine and tri-iodothyronine: concise communication.. PubMed. 23(3). 241–4. 7 indexed citations
14.
Shafer, Rex B., et al.. (1981). The role of Tc-99m phosphate complexes and gallium-67 in the diagnosis and management of maxillofacial disease: concise communication.. PubMed. 22(1). 8–11. 21 indexed citations
15.
McClain, Craig J., et al.. (1981). Hyperprolactinemia in portal systemic encephalopathy. Digestive Diseases and Sciences. 26(4). 353–357. 15 indexed citations
16.
Thiel, David H. Van, et al.. (1978). Evidence for autonomous secretion of prolactin in some alcoholic men with cirrhosis and gynecomastia. Metabolism. 27(12). 1778–1784. 27 indexed citations
17.
Elson, Michael K., Martin M. Oken, Rex B. Shafer, et al.. (1978). Comparison of two radioimmunoassays and a microbiologic assay for bleomycin. Medical and Pediatric Oncology. 5(1). 213–218. 6 indexed citations
18.
Thiel, David H. Van, et al.. (1978). Hyperprolactinemia and Thyrotropin‐Releasing Factor (TRH) Responses in Men with Alcoholic Liver Disease. Alcoholism Clinical and Experimental Research. 2(4). 344–348. 32 indexed citations
19.
Elson, Michael K., Martin M. Oken, & Rex B. Shafer. (1977). A radioimmunoassay for bleomycin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18(3). 296–9. 12 indexed citations
20.
Hearn, Walter R., et al.. (1970). Prodigiosene [5-(2-pyrryl)-2,21-dipyrrylmethene] and some substituted prodigiosenes. The Journal of Organic Chemistry. 35(1). 142–146. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026